|Mr. Thomas Bold||Pres, Interim CFO & Director||100k||N/A||1961|
|Ms. Patsy J. Trisler||VP of Regulatory & Clinical Affairs||60k||N/A||1948|
|Mr. Harmel S. Rayat||Founder, Chairman & Interim CEO||N/A||N/A||1961|
|Mr. Jatinder Singh Bhogal||Chief Operating Officer||N/A||N/A||1967|
|Dr. Roger Esteban-Vives||Director of Cell Sciences||N/A||N/A||N/A|
RenovaCare, Inc., a development-stage company, focuses on the acquisition, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System for spraying a patient's own skin stem cells onto burns and wounds for self-healing; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Pittsburgh, Pennsylvania.
RenovaCare, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.